Ryan P. Mynatt

A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity

Natalie A. Finch, Evan J Zasowski, Kyle P. Murray et al. · Antimicrobial Agents and Chemotherapy · 2017 · 235 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime

Bhagyashri Navalkele, Jason M. Pogue, Shigehiko Karino et al. · Clinical Infectious Diseases · 2016 · 181 citations · Full text

Medicine, Nephrology, Pharmacotherapy +15

Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin

Evan J Zasowski, Kyle P. Murray, Trang D Trinh et al. · Antimicrobial Agents and Chemotherapy · 2017 · 144 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy

Anthony M. Casapao, Susan L. Davis, Viktorija O. Barr et al. · Antimicrobial Agents and Chemotherapy · 2014 · 109 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study

Sarah C J Jorgensen, Evan J Zasowski, Trang D Trinh et al. · Clinical Infectious Diseases · 2019 · 100 citations

Pharmacy, Infectious Diseases, Pharmacology +16